Adjuvant dose-dense adriamycin plus cytoxan followed by dose-dense nab-paclitaxel is safe in women with early-stage breast cancer: A pilot study

被引：0
|
作者：
Pippen, J. [1 ]
O'Shaughnessy, J. [1 ]
Ambro, S. [1 ]
Krekow, L. [1 ]
Stokoe, C. [1 ]
Bhar, P. [2 ]
Iglesias, J. [2 ]
Robert, N. [1 ]
机构：
[1] US Oncol, Dallas, TX USA
[2] Abraxis BioSci, Onc, Los Angeles, CA USA
来源：
BREAST | 2009年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [1] Adjuvant dose-dense doxorubicin plus cyclophosphamide followed by dose-dense nab-paclitaxel is safe in women with early-stage breast cancer: a pilot study
    Nicholas Robert
    Lea Krekow
    Chris Stokoe
    Alicia Clawson
    Jose Iglesias
    Joyce O’Shaughnessy
    [J]. Breast Cancer Research and Treatment, 2011, 125 : 115 - 120
  • [2] Adjuvant dose-dense doxorubicin plus cyclophosphamide followed by dose-dense nab-paclitaxel is safe in women with early-stage breast cancer: a pilot study
    Robert, Nicholas
    Krekow, Lea
    Stokoe, Chris
    Clawson, Alicia
    Iglesias, Jose
    O'Shaughnessy, Joyce
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (01) : 115 - 120
  • [3] Dose-dense nab-paclitaxel vs paclitaxel with bevacizumab following adriamycin and cytoxan is safe as adjuvant therapy in patients with early-stage breast cancer
    Pippen, J.
    Paul, D.
    Richards, D.
    Bhar, P.
    Iglesias, J.
    [J]. BREAST, 2009, 18 : S57 - S57
  • [4] Dose-dense doxorubicin and cyclophosphamide followed by dose-dense albumin-bound paclitaxel plus bevacizumab is safe as adjuvant therapy in patients with early stage breast cancer
    John Pippen
    Devchand Paul
    Svetislava Vukelja
    Alicia Clawson
    Jose Iglesias
    [J]. Breast Cancer Research and Treatment, 2011, 130 : 825 - 831
  • [5] Dose-dense doxorubicin and cyclophosphamide followed by dose-dense albumin-bound paclitaxel plus bevacizumab is safe as adjuvant therapy in patients with early stage breast cancer
    Pippen, John
    Paul, Devchand
    Vukelja, Svetislava
    Clawson, Alicia
    Iglesias, Jose
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (03) : 825 - 831
  • [6] Dose-dense nab-paclitaxel (nanoparticle albumin-bound paclitaxel) in adjuvant chemotherapy for breast cancer: A feasibility study
    Burstein, H. J.
    Mayer, E. L.
    Peppercorn, J.
    Parker, L. M.
    Hannagan, K.
    Moy, B.
    Younger, J.
    Schapira, L.
    Wulf, G.
    Gelman, R.
    Winer, E. P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Optimizing dose-dense regimens for early-stage breast cancer
    Morris, Patrick G.
    Hudis, Clifford A.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (12) : 678 - 679
  • [8] Optimizing dose-dense regimens for early-stage breast cancer
    Patrick G. Morris
    Clifford A. Hudis
    [J]. Nature Reviews Clinical Oncology, 2010, 7 : 678 - 679
  • [9] Efficacy and safety of dose-dense neoadjuvant chemotherapy with nab-paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer
    Matsumoto, Akiko
    Jinno, Hiromitsu
    Naruse, Saki
    Isono, Yuka
    Maeda, Yuka
    Sato, Ayana
    Yamada, Miki
    Ikeda, Tatsuhiko
    Sasajima, Yuko
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (12) : 1119 - 1124
  • [10] Weighing a dose-dense option for adjuvant chemotherapy and trastuzumab in early-stage breast cancer
    Mayer, Erica L.
    Burstein, Harold J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (08) : 1198 - 1200
12345